Ana Morente-Carrasco

Affiliations
  • Experimental Hepatology and Drug Targeting (HEVEPHARM) Group, Biomedical Research Institute of Salamanca (IBSAL), University of Salamanca, 37007 Salamanca, Spain.
  • Area of Physiology, Faculty of Health Sciences, University Rey Juan Carlos, 28032 Alcorcón, Madrid, Spain.
ORCID: 0000-0001-5364-3948

Publications (2)

Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity.

Cells
Avec: Elisa Lozano , Paula Sanchon-Sanchez , Ana Morente-Carrasco , Luis Miguel Chinchilla-Tábora , José L Mauriz , Paula Fernández-Palanca , Jose J G Marin , Rocio I R Macias

Relevance of the organic anion transporting polypeptide 1B3 (OATP1B3) in the personalized pharmacological treatment of hepatocellular carcinoma.

Biochemical pharmacology
Avec: Maitane Asensio , Elisa Herraez , Rocio I R Macias , Elisa Lozano , Luis Muñoz-Bellvís , Laura Sanchez-Vicente , Ana Morente-Carrasco , Jose J G Marin , Oscar Briz

Réseau de co-auteurs

Elisa Lozano 2 collaborations
Jose J G Marin 2 collaborations
Rocio I R Macias 2 collaborations
Paula Sanchon-Sanchez 1 collaboration
Luis Miguel Chinchilla-Tábora 1 collaboration
José L Mauriz 1 collaboration
Paula Fernández-Palanca 1 collaboration
Maitane Asensio 1 collaboration
Elisa Herraez 1 collaboration
Luis Muñoz-Bellvís 1 collaboration
Laura Sanchez-Vicente 1 collaboration
Oscar Briz 1 collaboration